Accessibility helpSkip to navigationSkip to contentSkip to footer

Cookies on FT Sites

We use cookies and other data for a number of reasons, such as keeping FT Sites reliable and secure, personalising content and ads, providing social media features and to analyse how our Sites are used.

Accept cookies
Manage cookies
  • Sign In
  • Subscribe
Open side navigation menuOpen search bar
Financial Times
SubscribeSign InmyFT
  • Home
  • World
    Sections
    • World Home
    • Global Economy
    • UK
    • US
    • China
    • Africa
    • Asia Pacific
    • Emerging Markets
    • Europe
    • War in Ukraine
    • Americas
    • Middle East & North Africa
    • Australia & NZ
    Most Read
    • Federal Reserve shifts to quarter-point rate rise but warns of more to come
    • ‘Hybrid identities’: why Germany is updating its citizenship rules
    • ECB set to raise rates despite fall in eurozone inflation
    • Brussels urged to rein in Ukraine’s ‘unrealistic’ EU hopes
    • Italy to join forces with France in supplying air defences to Ukraine
  • US
    Sections
    • US Home
    • US Economy
    • US Companies
    • US Politics & Policy
    Most Read
    • Companies
      Sections
      • Companies Home
      • Energy
      • Financials
      • Health
      • Industrials
      • Media
      • Professional Services
      • Retail & Consumer
      • Tech Sector
      • Telecoms
      • Transport
      Most Read
      • Adani sell-off tops $90bn as share sale fails to ease crisis
      • ‘Extreme leverage’? Adani’s debt-driven expansion under scrutiny
      • Adani Enterprises calls off $2.4bn share sale
      • Perella Weinberg banker tied to insider trading probe found dead
      • How First Abu Dhabi Bank pursued Standard Chartered and ‘opened Pandora’s box’
    • Tech
    • Markets
      Sections
      • Markets Home
      • Alphaville
      • Markets Data
      • Cryptofinance
      • Capital Markets
      • Commodities
      • Currencies
      • Equities
      • Fund Management
      • Trading
      • Moral Money
      • ETF Hub
      Most Read
      • Live news: FedEx to cut global leadership team by more than 10%
      • Adani Enterprises calls off $2.4bn share sale
      • Perella Weinberg banker tied to insider trading probe found dead
      • US stocks jump after Fed announces smaller rate rise
      • Lebanon devalues official exchange rate by 90%
    • Climate
    • Opinion
      Sections
      • Opinion Home
      • Columnists
      • The FT View
      • The Big Read
      • Lex
      • Obituaries
      • Letters
      Most Read
      • End the Fed ‘put’
      • When good economic news may not be good news
      • The return of the ‘British disease’
      • Conservatives are too keen on money to win the culture war
      • Conservatives are forced to face the economic case for net zero
    • Work & Careers
      Sections
      • Work & Careers Home
      • Business School Rankings
      • Business Education
      • Entrepreneurship
      • Recruitment
      • Business Books
      • Business Travel
      Most Read
      • Shoshana Zuboff: ‘Privacy has been extinguished. It is now a zombie’
      • A new generation refuses to keep quiet on age discrimination at work
    • Life & Arts
      Sections
      • Life & Arts Home
      • Arts
      • Books
      • Food & Drink
      • FT Magazine
      • House & Home
      • Style
      • Travel
      • FT Globetrotter
      Most Read
      • The secrets of the Mercedes-Benz Holy Halls
      • Alexa Chung on the unpolished appeal of Indie Sleaze
      • Why I’m only buying five new things in 2023
      • Whitechapel Gallery offers thrilling landmark show of female abstract artists — review
      • Episode 3 of ‘The Last of Us’ shows TV at its best
    • HTSI
    MenuSearch
    • Home
    • World
    • US
    • Companies
    • Tech
    • Markets
    • Climate
    • Opinion
    • Work & Careers
    • Life & Arts
    • HTSI
    Financial Times
    SubscribeSign In

    Neglected tropical diseases

    Add to myFT Digest

    Add this topic to your myFT Digest for news straight to your inbox

    • Monday, 21 November, 2022
      Special ReportFT Health Centre
      FT Health: Future of Antibiotics

      The FT examines the causes and effects of an increasing global resistance to antibiotics: from the pressures doctors are under to prescribe them, to what new treatments are currently in the pipeline, as well as what role can the consumer play in reducing antibiotic use in the food chain

    • Monday, 24 October, 2022
      Special Report
      FT Health: Communicable Diseases

      Despite pledges to learn the lessons of Covid-19, caution is already waning. Plus: crisis turned a spotlight on healthcare services; climate change and urbanisation drive rise in ‘zoonotic’ illnesses; return of polio to US highlights impact of anti-vax campaigners

    • Monday, 27 September, 2021
      Coronavirus treatment
      Covid raises bar for infectious disease crisis response

      Pandemic laid bare the weakness of global health systems — but mobilised the greatest level of action seen in decades

    • Monday, 27 September, 2021
      Budget cuts hinder efforts to eliminate neglected tropical diseases

      As donated drugs near expiry, time is running out to distribute them, just as the peak season for infection approaches

    • Wednesday, 9 December, 2020
      Special ReportFT Health: Future of Antibiotics
      Covid delays India’s attempts to curb widespread overuse of antibiotics

      Some hospital schemes encourage proper antimicrobial stewardship but progress has been slow

    • Wednesday, 1 July, 2020
      FT Health
      Sharing work could ease mental health impact of pandemic

      Catharina Boehme of Find, path of the pandemic, racism and public health

    • Wednesday, 6 May, 2020
      FT Health
      FT Health: We’re not all in this together

      Inequalities laid bare by pandemic, Seth Berkley on vaccines, malaria setback

    • Friday, 14 February, 2020
      FT Swamp Notes
      What I learnt from lunch with Roger Stone

      I have little doubt that Trump will pardon his associate whatever sentence he receives

    • Wednesday, 3 July, 2019
      #techFT
      Broadcom set to secure Symantec deal

      Tesla delivery milestone, fen tech tigers, corporate travel apps

    • Sunday, 28 April, 2019
      Scott Ratzan
      Childhood vaccination must not become a wedge issue

      Rebuilding confidence in vaccines should include addressing the concerns of hesitant parents

    • Friday, 26 April, 2019
      Health
      FT Health: Taking the fight to malaria

      Abdourahmane Diallo interview, drugs by drone, antibiotic alert

    • Friday, 5 April, 2019
      Health
      FT Health: WHO maps out health inequalities

      Bill Gates interview, food insecurity, deadly diets

    • Thursday, 28 March, 2019
      David Pilling
      The world must wake up to the threat of latest Ebola outbreak

      The number of confirmed cases has passed 1,000, making it the second worst in history

    • Friday, 12 October, 2018
      Health
      FT Health: The global scourge of mental ill health

      Chris Flowers, digital distraction, shrinking pizzas

    • Friday, 5 October, 2018
      Health
      FT Health: Cancer policy struggles to keep up with science

      Jacqui Shea of Aeras, tobacco tussles, toilets for all

    • Friday, 21 September, 2018
      Health
      FT Health: D-Day for tuberculosis

      Mariam Claeson, Coke and cannabis, the toxic school run

    • Friday, 7 September, 2018
      Health
      FT Health: Quality not quantity

      Magic mushroom trials, inactivity, female-friendly toilets

    • Friday, 31 August, 2018
      Health
      FT Health: Africa squeezed by burden of disease and lack of investment

      Children under pressure, STD surge, Krokodil and Monkey Dust

    • Friday, 10 August, 2018
      Next Act
      FT Health: Longevity and social change

      Martin McKee on UK public health, anti-vaxxers advance, news in briefs

    • Friday, 3 August, 2018
      Climate change
      FT Health: Climate change is a public health problem

      Pierre Meulien of the IMI, price gouging, sick stories

    • Friday, 27 July, 2018
      FT Health: Act now to reinvigorate efforts on Aids

      Guest curator Peter Piot’s picks of the week and interview with Aids campaigner Nduku Kilonzo

    • Friday, 20 July, 2018
      Health
      FT Health: Drug resistance, pandemics and the vaccination gap

      New report reveals that fewer than 100 countries have a plan in place to stop overuse of antibiotics

    • Friday, 13 July, 2018
      Health
      FT Health: Is there a doctor on board?

      Carlos Morel on epidemics, breastfeeding battle, Trump v Big Pharma

    • Friday, 8 June, 2018
      Health
      FT Health: An urgent need to invest in mental health

      Transformational business, sugar skirmish, and ‘super gonorrhoea’

    • Friday, 1 June, 2018
      Health
      FT Health: Cancer optimism tempered by ‘financial toxicity’

      Ilona Kickbusch, tobacco breaks hearts, smart toilets

    Previous page You are on page 1 Next page

    Useful links

    Support

    View Site TipsHelp CentreContact UsAbout UsAccessibilitymyFT TourCareers

    Legal & Privacy

    Terms & ConditionsPrivacy PolicyCookiesCopyrightSlavery Statement & Policies

    Services

    Share News Tips SecurelyIndividual SubscriptionsGroup SubscriptionsRepublishingExecutive Job SearchAdvertise with the FTFollow the FT on TwitterFT ChannelsSecondary Schools

    Tools

    PortfolioToday's Newspaper (ePaper)Alerts HubBusiness School RankingsEnterprise ToolsNews feedNewslettersCurrency Converter

    Community & Events

    FT CommunityFT Live EventsFT ForumsFT Board DirectorBoard Director Programme

    More from the FT Group

    Markets data delayed by at least 15 minutes. © THE FINANCIAL TIMES LTD 2023. FT and ‘Financial Times’ are trademarks of The Financial Times Ltd.
    The Financial Times and its journalism are subject to a self-regulation regime under the FT Editorial Code of Practice.
    Financial Times

    International Edition

    Subscribe for full access
    • Switch to UK Edition
    • Top sections
    • Home
    • World
      • Global Economy
      • UK
      • US
      • China
      • Africa
      • Asia Pacific
      • Emerging Markets
      • Europe
      • War in Ukraine
      • Americas
      • Middle East & North Africa
      • Australia & NZ
    • US
      • US Economy
      • US Companies
      • US Politics & Policy
    • Companies
      • Energy
      • Financials
      • Health
      • Industrials
      • Media
      • Professional Services
      • Retail & Consumer
      • Tech Sector
      • Telecoms
      • Transport
    • Tech
    • Markets
      • Alphaville
      • Markets Data
      • Cryptofinance
      • Capital Markets
      • Commodities
      • Currencies
      • Equities
      • Fund Management
      • Trading
      • Moral Money
      • ETF Hub
    • Climate
    • Opinion
      • Columnists
      • The FT View
      • The Big Read
      • Lex
      • Obituaries
      • Letters
    • Work & Careers
      • Business School Rankings
      • Business Education
      • Entrepreneurship
      • Recruitment
      • Business Books
      • Business Travel
    • Life & Arts
      • Arts
      • Books
      • Food & Drink
      • FT Magazine
      • House & Home
      • Style
      • Travel
      • FT Globetrotter
    • Personal Finance
      • Property & Mortgages
      • Investments
      • Pensions
      • Tax
      • Banking & Savings
      • Advice & Comment
      • Next Act
    • HTSI
    • Special Reports
    • FT recommends
    • Lex
    • Alphaville
    • Lunch with the FT
    • FT Globetrotter
    • #techAsia
    • Moral Money
    • FTfm
    • Newsletters
    • Video
    • Podcasts
    • News feed
    • FT Live Events
    • FT Forums
    • Board Director Programme
    • myFT
    • Portfolio
    • Today's Newspaper (ePaper)
    • Crossword
    • Our Apps
    • Help Centre
    • Subscribe
    • Sign In